Related Experiment Video
Updated: Dec 15, 2025

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
MiR-1587 Regulates DNA Damage Repair and the Radiosensitivity of CRC Cells via Targeting LIG4
Ruixue Liu1,2, Liping Shen2, Chuxian Lin2
1Department of Radiation Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People's Republic of China.
Abstract:
DNA is subject to a range of endogenous and exogenous insults that can impair DNA replication and lead to DNA double-strand breaks (DSBs). The repair capacity of cancer cells mediates their radiosensitivity, but the roles of miR-1587 during radiation resistance are poorly characterized. In this study, we explored whether miR-1587 regulates the growth and radiosensitivity of colorectal cancer (CRC) cells through its ability to regulate DNA Ligase4 (LIG4). We found that CRC cells in which miR-1587 was overexpressed inhibited cell growth and promoted apoptosis through increasing DSBs and promoting cell cycle arrest. We found that overexpression of miR-1587 significantly inhibited LIG4 messenger RNA and protein expression and further revealed the ability of miR-1587 to directly bind to the LIG4-3'-untranslated region through dual-luciferase reporter assays. More notably, miR-1587 mimics increased the radiosensitivity of CRC cells. Taken together, we show that miR-1587 overexpression enhances the formation of DSBs, arrests CRC cell growth, and enhances the radiosensivity of CRC cells through the direct repression of LIG4 expression. These results reveal novel roles for miR-1587 during DNA damage repair and the radiosensivity of CRC cells. This highlights miR-1587 as a novel therapeutic target for CRC.
Insights
MicroRNA-1587 (miR-1587) enhances colorectal cancer radiosensitivity by inhibiting DNA Ligase 4 (LIG4) expression, leading to increased DNA damage and cell cycle arrest. This suggests miR-1587 is a potential therapeutic target for colorectal cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- DNA double-strand breaks (DSBs) are critical lesions impacting DNA replication and cell survival.
- Cancer cell DNA repair capacity influences radiosensitivity, but the role of specific microRNAs, like miR-1587, in radiation resistance remains unclear.
- Colorectal cancer (CRC) presents a significant health challenge, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of miR-1587 in regulating the growth and radiosensitivity of colorectal cancer (CRC) cells.
- To determine if miR-1587 affects DNA Ligase 4 (LIG4) expression and its impact on DNA repair.
- To explore the potential of miR-1587 as a therapeutic target for enhancing CRC radiosensitivity.
Main Methods:
- Overexpression of miR-1587 in CRC cell lines.
- Assessment of cell growth, apoptosis, and cell cycle progression.
- Measurement of DNA double-strand breaks (DSBs).
- Analysis of DNA Ligase 4 (LIG4) mRNA and protein levels.
- Dual-luciferase reporter assays to confirm direct binding of miR-1587 to the LIG4 3'-untranslated region.
Main Results:
- Overexpression of miR-1587 inhibited CRC cell growth and promoted apoptosis.
- miR-1587 overexpression led to increased DSBs and cell cycle arrest.
- miR-1587 significantly repressed both LIG4 mRNA and protein expression.
- Dual-luciferase assays confirmed direct binding of miR-1587 to the LIG4 3'-UTR.
- miR-1587 mimics enhanced the radiosensitivity of CRC cells.
Conclusions:
- miR-1587 overexpression enhances DNA damage, arrests cell growth, and increases radiosensitivity in colorectal cancer cells.
- These effects are mediated through the direct repression of LIG4 expression.
- miR-1587 plays a novel role in DNA damage repair and radiosensitivity in CRC.
- miR-1587 represents a promising therapeutic target for colorectal cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...

